Arphra
live
S&P 5007,500.58+1.08%
NASDAQ30,406.19+2.48%
DOW51,564.7+0.14%
VIX16.78+2.32%
US10Y4.45-0.27%
EUR/USD1.1506-0.93%
GOLD4,300.5-1.26%
WTI75.22-0.90%
BTC64,442.01-1.87%
S&P 5007,500.58+1.08%
NASDAQ30,406.19+2.48%
DOW51,564.7+0.14%
VIX16.78+2.32%
US10Y4.45-0.27%
EUR/USD1.1506-0.93%
GOLD4,300.5-1.26%
WTI75.22-0.90%
BTC64,442.01-1.87%

TECH

Bio-Techne Corporation
HealthcareBiotechnologyUSUSDPeers →
$56.26
LiveJun 22, 2026
AI Brief
Market cap
$8.81B
52w range
43.20 – 72.16
P / E
—
EPS · FY 2025
$0.46
Volume
591.11K
Revenue · FY 2025
$1.22B
+5.23% YoY
OverviewFundamentalsValuationMarketOwnership & flowNarrative & AI
PricesTrendEarningsEstimatesCall languageAnalystsRelated securities

Explain this page

Arphra AI
Equity listings
1
Corporate bonds
0
Convertibles
0
Peer equities
10
Equity
· 1 venue

Cross-listings

SymbolExchangeCtryCcyMkt cap
TECHprimaryNasdaq Stock MarketusUSD$9.07B
Listed options →
Equity
· 10 names

Peer companies

  • RVMDRevolution Medicines, Inc.$29.65B
  • MRNAModerna, Inc.$17.99B
  • JAZZJazz Pharmaceuticals plc$12.72B
  • MDGLMadrigal Pharmaceuticals, Inc.$11.78B
  • EXELExelixis, Inc.$11.1B
  • BMRNBioMarin Pharmaceutical Inc.$10.4B
  • QGENQiagen N.V.$7.06B
  • CORTCorcept Therapeutics Incorporated$5.52B
  • CAICaris Life Sciences, Inc.$5.22B
  • RNAAtrium Therapeutics, Inc.$208.37M
Fixed income
· no mapped debt

Corporate bonds

No corporate bonds mapped to this issuer’s LEI. Many equity-only names carry no public debt, or the LEI bridge isn’t resolved yet.

AI read · securities complex

Arphra AI